UNGEN DAVIES CANCER FUND CIO Charlty reglstration number 1160922 ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 IAARCH 2023 LINGEN DAVIES CANCER FUND CIO LEGALAND ADMINISTRATIVE INFORMATION Trust88s Mr M Harris (Chairn￿n) Mr T Cooper Chairman) Mrs C H Thomas ￿￿sUrer} Dr N N Srihari Dr G Eatough Mrs F K Hutchesc Mrs J L Beaver Mrs VA E(Jwards Dr J R Johnson MBE MrsAJ Thom MBE DL MrA H Killey (P4)wntod 22 November 2022} Charlty number 1160922 Prfncipal addross Fundraising Off¢e lo Hamar Centre Royal Shrev*sbury Hospital Norlh Shrewsbury Shropshire SY3 8XQ Audltor Emstrey House Shrewsbury Bustne5s Pa Shtewsbury SY2 6LG Bankers Santander PLC Brid￿ Road Brx)Ile Merseyshle L30 4GB Utsyd5 Bank PLC 2138 Coventy Road Sheldon Birmingham B26 3JW Virgin Money PLC Jubilee House )sforth Newcasle ￿[￿ Tyne NE3 4PL LINGEN DAVIES CANCER FUND CIO CONTENTS Trustees. rew)rt stst8m8nt of Trustees. resportsibililies 11 Independent audltorfs rep)rt 12-14 ststement offin8nual ath[t￿s 15 Balance sheet 16 statement of ￿sh 17 Notes to the finanaal statements 18-30 LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT FOR THE YEAR ENDED 31 MARCH 2023 The TnJstees present their rep(￿1 and a￿nts for the year ended 31 2023. The finan(#81 st*ements have bew ￿Pared in accordan￿ wilh Ihe accounting rM)licies set out in rKile 1 to the finanual statements and comply V￿th the charitys govwung do(#JmenL the Charrties Aci 2011 and "ArLounting and Reporbng by Charities.. Ststement of ReuJmmerKled Practice appltsble to charrbes preparing their accounts in accordance wtth the Financial Reporting Standard appli12ble in the UK and Republic of Ireland IFRS 1021. las amended for accountirrfJ pericmts commenung 1 January 20191. Obj8Ctives and a¢tfvitles Lingen Davies èxists to enhan￿ rxn(*r $8rvicss and imwove INes. here in our community. In line wih our Constriuknon. the ot4eCt of the L*arity i& lal Tho reli8f, whdly ￿ mainty of carw patients reS￿l￿j in Shr0psh￿e. Telft)rd and Wreknn and Mid Wales (the charity's area} in parbajlar N)t exciusivety by wovvJrKJ: (il Grants to suprx)rt the work of ￿rK*r IwlthcAre wOfesscTh￿, based within and serwng ¢8n(w patients in the charitys area aThJ lill Services dire& to Cancer p*ients rf the TnJstees deem approwmte {bl The wevention of c2ncer by rdi%ing awarenoss in the tharit￿$ wea Noti￿Standi￿j that these may a150 benefit some C￿￿Inc￿can￿ Pa￿nts residwMJ outside the charivs area. The Trustees have paKI due regard to guwJarTh ISSU￿ by the Charity Commission in deciding what aCtiV￿eS the charity should undertake. The Trustees consider the objg¢tiv8s and activit*s ofthe tharity are of a public benefft. A¢tlvltles of tha Charity Lingen Davies 8XiSts to enhance cancer servw aThl inyove Irves in Shropshire. TeKord & Wrekin, and Mid Wales. We do this through fvA) main streams ofwork. Grnnt malting The Charity raises furKts for propcts whth make a FKNbve difference to the lives of liwng ￿th cancer in Shropshire, Tefford & Wrekin and Mid Wales. Donations ar8 made to trK)SPitals. charities. and other bodies to assisl with purchasing ¥wxalist equipment. improving trealment spaces and supporbng community-based projects lo improve the heahh and we1lbe￿g of people living vrith and beyo￿1 (xntx. Grant appIl￿tiOnS are assessed by the Grants Committee. a SLEb-committee of the Twstee Board. and then confimi¢d by the trustees whère the value of the grant requires this. Grants are 85sessèd against the aims and objtscts of the charity. ensuring that the propc6al show5 a dear benefft to cancer patients and seNices. ctose oJmmunK?lion is maintained with grnnl reciW to ensum that grant mthng process is as successfijl as possible and achleves maximum public benefiL LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Raising Awareness The tharity delivers the LiveLife Can￿r Awareness ser￿Ce. a free ￿lth-pr￿￿rt service available to Commun￿8$ throughout Shropshire. Telford & Wrekin, and Mid-wa￿. By reaching out into the wider communty LÈngen Davies Canc*r Fund is worknng to ￿1p prevent cancer by actively tslking to the public. helping people fecognise the signs and symptoms of canw. encouraging them to seek treatm8nl earlier, and a{￿p1 cancer screening invitations. The LiveLife Can￿r Awareness SeNice is available to ￿MmUn￿eS througTrK)￿ the regKJn as a mobile facality. Communty groups, oryJanisations. largw(zle event organisers can acc￿$ arTrd book the free resource to attend their meeting or event. The charity aL%o offers In-h<￿tse sesS•X￿ for corF¥xats partners and local businesses who may wish to run cancer awareness courw ¢x days. Service Delivery Our focus on 0[￿eT prevention. s(¥eening and eaty diagnosis has tsk&i great strides fOr￿ard this year. We have been tr8mendw$ty a(Jive with local health partn￿5. communty organisations, and a wde ￿ety of other dubs, businesses and enterprises to promote our LtYeLrfe messaging. encourage scxeening uptake, 8nd to Share signs ar￿ symptoms of cancer with the ￿der puilic at 8 numlxr of events through0￿ the reg40n, with the ambition of incre85ing eady diagnosis. Because of the suc£ess of this work and increasing demand. we appointed a LiveLrfe Health Engagement Coordinalor in October 2022. promoting our exisb.ng Heath Engagement Offi￿r to be the over811 LiveLrfe Project Lead. We were delighted to be suc￿SsfUllY awarded NHS fvnding {vra NHS Shropshire. Telford & Wrekin Integrated Care Board IIC811 to Co-deliver the co￿20* proj8¢ in partne￿hip aube (another IOCAI charity who prowde $8rvic8s for the Ix)mmunity in North Shropshire and the border txjunties). This Project is designed to increase th8 uptake of cancer SC￿ning in communibes who are likely to engage in SLxeening progrdmmes, particulady focLtsing on people falling into the 20°A most ¢Jeprived c(Mnmunities in the UK. Delwery of the project has been wa our 'Cancer Champions, model and is proving er￿￿slY successfijl. Tho project h8S SUPPOrted the development of relationships with communities throughout the regNm through our work to identify and recrutt volunteer Cancer Champions. To support delivery. WÈ appointed a s￿[fiC Can(w Champion Ccrt)rdinator for T81fr>rd & Wrekin Iwtth Qube appointing in the Shropshire region). although we have relair*d delivery oversight of the project and lead on reporting requirements for the ICB. The Can￿r Champtons m(MJel has invofved the ￿eatiOn of a dgJKated Cancer Champions websTte. and series of multi-lingual wdeos, lo ensure messaging arKI promobon about Ihe Im￿rtanCe of health screening reaches as wide an audience as Fwsible. From the first training sessions in De￿mber 2022. we have recruited and trained 44 Cancer ChaEnpions by the end of March 2023, meaning we are well on tsrgel to meet the ambition set by NHS Shropshire. Telford & W￿kIn ICB lo train 50 Cancer Champions wilhin 12 monts. The proieca has already been promoted as a best practi￿ example at a national NHS England level. Building on the succgss of LiveLife and the car￿ Champions mrxlel in Shropshire. Telford & W￿kIn. we hav appointed a Lingen Dawes-fvnded Powys Can￿r ChampK)n Coordinator who will work lo spread our cancer 8warenes5 messaging in the region. The app)intsnent of a dedtcated role to focus on Powys Complements builds upon our new physical presen￿ in the regi￿. The launch of our new charity hub in Plas Dolern. Newtown, Powys in March has been very well-received by stakeholders in regK)n, and we are now focused on growing links in the a￿a wilh he8ith partners, suppM)rters. and vdunteers. In parti￿lar. our links ￿ the Powys T&aehing Heakh Board. and colleaguès at The Brery)n Trus( and Powys AssociatK)n of Voluntary Organisation5 {PAVO) have grown rapidty. developing strong Wofking relationships to tske forward can￿r awareness in the region. LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 This Ph￿Cal g￿Vrth and new recruitment to the staff team was made possible by the generou5 leg8Gy left to the charity by a Mid Wales reshlent. We remain dedicated to sperKling the money to benefit residents and the commLFntty of Powys and Mid Wales. We are keen to expl￿ options for commissM)ning our own n0ndin1￿1 SUp￿rt swwces for people with cancEr. We have undertaken a headline rewsw of cUr￿nt prowsion of so(?81 and emotional support services available lo people affected by can￿r in our region. a view to k*)knng at ways to fdl gaps in provisi(Trn. wherè these become apparent. We have also launched and continue to utilise tyJr LiveLite Can￿r Awareness van. Thanks to a £95.0(K) donation w8 have purchased a state of the art exhibition Wdn whicth is now out on Ihe roads. raisitvJ awareness about tho charity, health engagement and attending fundraising events across the reg￿. Fundraising Adi¥ltles We are absolutely delighted to report that for the se(x)nd year running we have surpa&sed the £1.000,000 income mark, with a total income this year of £1,139,365 {£1,077.072 in 2022}. We are very proud of this achievemènt 8nd it is testament to the hard work and deditsts.on of the s￿￿ team. as well as all those who support and volunteer for us. During the COVID-19 years when many charities (Iw to make red￿r￿ana9￿. we GThtinued to invest in our stsff t88m, and this has been justified by our onwng growth and perfOMwn￿. We continue to develop and deliver a robust iTrhouse e¥￿ts programft￿ that has wide appeal and geogrnphical reach. We have inlrcyJuGed new challer¢ge events to the s(a)edule for Ihis year and wll conttnue to ¢urate a varied programme. We ate proud of our corporate support and (xjntinue to develop and enhance th8se relationships. Other income sI￿amS under (Sevelopment Ir￿L¥je our Twsts a￿1 Foundations. applications, maior donors, and w8 are building on our Wills and Legacies. streawn. We remain aware of Ihe need to ènsure future In￿Me Is sustainable, and cannot rety on receiving regular legaoes but we can work towards developing olher streams of income. and promoting ourselves mre widety so that Lingen Davies is at the foretront of people's minds when writing wlls and considering illduding us for a kgacy donati(￿. The appointment of two new part￿1￿ fundraising Offi￿r$ year ahead {to c>)ver matemtiy leave) wll mean we have additson81 capa*ity to develop strea￿￿ and support rmre thir&party ￿ndraiSe[S. Fundralsing Standards Information CA162A The charity receives the majority of it's fijnds from the w￿1C. lal The charity undertakes funt>raising though (yjr intemal resources and staff team. We do not rxjmmission a professional fund-ralserl￿mMe[[1al participator for Ihese" {b) The charity is registered wth the Fundrdtwng Regulator and abides by ￿￿)d practl(8s standards set out by thè regulator. The charity's intemal Guide to Fundrnising refi¢(ts these a￿1 gNes infonYJation to slaff and volurrteors about how to fvThJraise legalty. elhi￿llY and With￿ g(￿ fKactice staThJards: Icl The charity monitus fund43ising activtks via the Trustee board., Idl The tharity re(thed complaints atMyJt aG*wknes fvrthe purwse of hJndraisiTr3 during this year (el The charity has adopted winciples of GDPR legislation and has safeguarding poliaes to protect the ijata of vulnerable people and other members of the public from: lil unreasonab￿ intrusion ￿ a Fersons. prrw. lill Unreasonable persistent approaches ts Ihe of solhibng or olhemse procuriThJ money or other prr4)ety on behaTrfofthe chariiy. liul Pl8￿ry undue pressure an a per￿ to grve money or other waperty. LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Achievemerrts and perfornianee As tho restrictions of the pandemic havè Wun to ease. we have seen a grrfftwth in the number of third-party events bèing deliv8r8d on our behaff. as well as growth in the number of people wanting lo participate in our own inthouse deltvered events. This. coupled wth the dNetsifitstion of our fvnding stfeams and building on the excellent work undertaken by the stsff team during 2021m. means that we have had anothèr very successful year. We are absolutely delKJhted to h8ve raised over £1 million I￿ Ihe second year in a row and for only the second time in the Charity's history, which is a fantsstic achievement. This is a testsmenl to the hard work of our staff team and to the mmitment and gen8msty of oJr SUpport￿S throughout the communtty. INhik we are very pleasèd with this success. we are mindftjl of (x>ntinued I￿1 and glcthl challengès. We a￿ worktng hard with the staff tèam and across the Board of Trustees lo ensur8 that this a￿Oath ar￿ level of achi8V8m8nt is Sl￿Inable in the longer temi. To support the growth of the charity. the desi￿ to m8intain and irKrease the level of income seen in 2021122, and the initial su¢¢e&s of our call￿r awareness worL we have rewtted a number of new members of the staff team. In September 2022. we appointed an events marketing coordinator to SUPFX)rt OUT fijndraising programme. who has been 8 key part of driving our ftjndraising fotwarrjs. This appointment has also given us I￿￿eased capaaty wfchin ¢ornmuni¢8lions and marketing, an area of thg offering great fftntial to increase brand awarertess and support for all charilable activitses and seNice delNery. We h8ve a150 appointed a new Finance Assistant who joined the team in March 2023 to allow us to maroge more of our fuwnryal reSpor￿￿billtjeS intemalty and for the Head of Operations to I￿￿S on their key duties, and the opening of our secorKI office k)catyon. Our CEO tc¥)k matemity leave from the end of March 2023, so folbwing an external recrUit￿nI pr￿e$s, we appointed an interim to cover from msd-February 2023 onwards until th8 Start of Mar(* 2024 when the CEO is du8 Éo return. Having the role of CEO covered during this period is cruaal to alk)w us tr) suuxssfulty rL)nb'nue to deliver the 8thievements we've seen during 2022r23 and e£Jntinue lo grow Ihe charity. Chjr LiveLife programm8 has (x)ntHiued to go from strength to strength aml to delNer this we have appointed a new part-time Health Engagament C¢xYdinator into a 24-month Fx)sl from O¢tober 2022. to support the r￿4 LiveLrfe Project Lead. As previoLtsly noted. we have re(TJtted Canw champ￿ coordinato￿ into Ttslford & Wrekin {NHS funded Juty 2022) and Pcwys (March 20231 who arg already having a great IM￿ in the relalivety short ptsriods they have been in post. The charity is committed to supportlng people affected by can￿r acro&8 Shrq)shire, Teword & Wrekin and Mid- Wales. Up until this yeaT. amhough we have had a great supwrter base in the region, we've not had a physcal prèsence in Wales. Due lo the generous legacy we receive(l from a P(V•VyS resident in the last financial ye8r, we've been able to develop a strategic ptan to grow our f￿tprint tn Wa￿, which o)rnmenced wth Ihe opening of our NeWt{￿M offic8 in M8rch 2023. Based at Plas DoleTh¥ abngsidè PAVO ¢x)Ileagues. we are extremely well-plaefjd lo build our relat￿shIpS with stsktholders the area. 9rowing tr*)th Wf fundraiwng armj canw awareness opportunities. 2022123 also saw Iho launth of Ihe ican seNic8 in Shropthire and Telford & Wrekin. a holistic programme sUppO￿ng physical mental and emotional wellbeing. delivered by qualtfswj health professionaL%. Following a highly successful pilot. we were very pleased to be able lo confirm grant fvnding for two years (in the first Instan￿), and the programme launched in June 2022. By th8 end of the year. Ihe service has received over 286 rèferrals. and had ovar 1000 s8ssion attendances. Excitiroly. a research team at Unrversty Centre Shrewsbjry has picked up on the impact of the programme 8nd has drafted a fijll academic paper based Up￿ the early ican outcomes. This is at a review stage prior to fvll Submissi￿ and pulAi(ztion. Nexi steps are to continue to gruw numbers in Shropshire, Te￿Ord & Vvrekin. as well as L4un¢h the service in Powys. during 2023124. We are excited to be exparKling our woth beyornl our tradthnal fundraI￿￿j fcf major appeals. bul still have fundraising al the heart of what we do. We are well aware of the pressures faung our heath seTwces and on peoples, finances and wll mairtsin ck)se links ￿ kncal NHS arKI l¢xal autlx)rity bodies to ensure our plans complement widèr strategies and contribute to a better experien￿ for people Irving wth cancer in our region.we remain in dose conversation Wi Shrewsbury and Telford Fh)spilals Tmst warding Op￿￿S for fvnding of equipment and new technologies a(x05s the finanrAal ¥ectrum over the c￿ming year. LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 23 Funde ican Ygar One (June 2022 onwanls) £164.100 The oveThthelming sU￿esS and po&tive reaction to the pilot programme of this work has altowed us to agree ￿rKlIng fc* a further to three year peric*J in the first instan￿. ican is a holistic wellbeing programme addressing arKI physical. mentsl, and emotional wellbeing. Run by the team at Lrfestyle Ftkness. an OTganisation of kK31 health professionals who previously delivered the Get Actyve Feel Good scheme, we have every confidence in the quality of their work, and their ability to deliver excellent standards and resL51ts. Importantty. this SerV￿e is free for patients to acxw, and patients can self-refer into the prc*Jrdmme. as well as be referr￿1 by their m￿￿al Profes￿￿￿1. Patients living wtih and beyond can￿r can attend ten p18nned and bcalty led group sessions of tailo￿ activity lexercisel arKI infOm)alionlgdiJ￿ti0n, with behavKJur suppyl. &%h session indudes a tailored education session thin a group setting around sel themes and activibes which have been Mlentified throu9h patient feedbackl concems raised durkThJ the GetActive. Feel G¢xyJ pr(NJramme. ican is delivered online and also at locations in Shrewsbury. Telford and Oswesty, ￿lh a longgr-term view lo offar sessions in Powys. and additional loc*ons in Sh[opshi￿, TeWord & Wreknn as demand and referrals increase. Com lementa Th•ra l•s- Oncology Wanls £11.11)O This projed is delivered by Sevem Hospice for in-patients staying on cance¥ wards at the Shrewsbury and Tell¢)rd Hospitals. Complemèntary therapies can help patients wth pain relief, mentsl health. arKI wellbeing during their trealmenL which can inevitably and understsndably be a stressful and drfficAJIt time for them. Patients (an benefit hugety from rei*Mng complementary therapies during their tTe8tment. and while it was pul on IK>kl during the pandemic. it reslarted in September 2021 and was much wekx)mod by staff and patients alike. We agreed to fund this WO￿ for three years ar￿ pa¥J out 2 of lunding in 2022r23 and ￿TrI fund Year 3 in 20231 24. During 2022. 279 p8tients and their families benefitted from seNces induding aromatherapy, reflexology and massage. with very positive feedbac* received by Tntst slaff. Scal coolin ma¢ in - £15,353 The funding ol this project was inspired by a group of ladies all aged in their 305 and under, who met whilst undergoing themotherapy at the Lingen Davies Cancer Certre. Ci)oling ￿pS are used during treatrnent as a means of preventing hair ioss. The grr¥Jp furwJr8ised for an additior)al for use by fvture patients- and we agreed to fvnd a large chunk of the addttional equiprn8nL We are delighted to say this (3p affived onsite in the SpriTh3 of 2023, wlh plans for this lo t* operdtional and in use by patients in Summgr 2023. LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 ur anner and Clinic Rooms £813.447 whi￿ fijnding for this was ¢Jelivered in the last rinanclal year, we have seen the realization of this large s¢2le appeal this year wth patients and staff fulfy utslizing the 8dditional space. We invited our Friends of Lingen Dawes and varK)us I￿al Rolarians to a dedic8te(S tour of the Radiotherdpy Department in October 2022. We saw for ourse￿e$ and heard from the Radiotherapy team about ihe sib've impact tho new CT Scanner has delivered enabling greater efficyencaes. accuracies of treatment. and ensuring more patients can be seen arnl treated wtlw)ut delay. K￿Ck Cancer- £7,500 Building on our relationship with Shrew5bury Town in the Community Ithe ¢ornmunity oulreaeh ami of our local football dubl. lQck Cancm was inib81ty launched online during the pandemic. This project helps people to tske part in physical activty to improve Iheir mentsl and physical wellbeing as they experience cancer. Funding for this proseth completed at end of March 2023 but we will ¢yMtinue to develop wothng relationships and joint fvndraisiThJ iniliatrves with the F¢y)tball ChJb arKI its community am). Radar Ke - Q018 This project was inilialty Intr(KlU￿ to us thrDugh at th8 North Shropshire Primary Care Network who NJentFfied a need for peOe k'ving Ihryth cancer to have easier #￿esS to public faalibes enabling them to live lrfe well. We purchased IIKX) radar keys gmng access to public disabled ￿lets. these are often required by people whose cancer. or the effects of their treaknent. moans Ihat they need to acrxs a toilet qUi￿Y, or require space and faci5ities lo deal with things such as stomas. when they are aw8y from home. Patients are offered the keys via their cancer (Are ¢>)ordin8tor in their GP practice. as part of their usual apwnbnents. We are now working with Prsmary Care Nthorks across the c4)Lsnty arvj up to March 2023 have Suppl￿ ralar keys to over 150 p8b.enls 8cr05s our region. Feedback has been incredibty posthe and a story wrttten about the project and its intti81 ￿[plent reached more than 10,Tr)O people on s￿￿al media - gerberating addib.onal awareness. fvndraising aclivty, and requests direct to the staff team from patients ￿ SUPFKWtets athng for keys- we were happy to supply. Televisions Ward 23 Isolatlon - £1.512 Patients in Warrj 23 are imrrtune-suppressed and therefore spend a significant period of time in isoL4tion. in some ￿Se5 UP to three rrK)nths. In Feb 2023. we awatded a grant lo thè Tru51 to provide eight Sfflart TVS whid> show broadcast ointent bul also alk￿ paler7ts to stsy in touch with family arKI friends via the intemet. LlveLSfe Cancer Awarenes £92.826 As well as provKling lur¥Js for external proieLts. we continue to expand our health PTomotion work wtth the LiveLife Proje¢t- enoxjraging eaty diagnosi% wherever w)ssible. We have attended public events, workplaces and high streets gmng inf0m￿tion atrK)ut the èady SIgrk￿ and Symptoms of cancer, and encouraging people to seek help rf they are worried about char¥Jes in their b(yty. We have given oul many hundreds of free sunscreen sachets and gwen tslks lo u)mmunty groups throUghC￿t Ihe region. We are now looking at developing solutions to plug gaps idenur￿￿ by our ￿nsultation prOj￿t in areas of wellbeing and emotional support that we may be able to fill in the future. Building on our extsting links in Powys is a large pgrt of this th ping foMard- we wart to ensure patients across our entire region can access the best support services Irrespecti￿ of Whe￿ Ihey live. LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR fHE YEAR ENDED 31 MARCH 2023 Thanks The Tftjstees wish to axpress thanks to thg of ShropshiFP. TeWord & Wrekin. ar￿ Mid Wales, whose support for the charity has been e￿Ptional On￿ again. The ￿J￿nt ecx)nomic climate. increases in the cost of iving. presents ongoing thalknges across the charity se(Xor and yet we continue lo be amazed by the willingness of our supporters to give their time, rrK)ney ar￿ g(Kthll to support us antl people affected by can￿r in our region. We would also lik8 to thank thè staff team and (x)ThJratulate them ￿ther ex￿p￿onal year of fvndrdising, development. arKI 5eNce delivery for the chariiy. We also thank our patrrm. Lady Jane Heber-Pwcy. for continued supwt and generosity. None of the charity's work W￿k1 be r￿sIble 1mlhc￿rt the ￿)mmi1Ment of the staff and volunleets. and the TnJste8S arè vèry grateful for this. Finally, Trustees would like to give their sFrKere thanks in recc#Jntbon of the hanl work and dedication of our outgoing Chair of Ihe Board of Trustees M8n¢Jy Thom MBE. Mandy has served two lemis as Chair, and steered the Lingen Davies Tnjstee Board thrtyjgh an ethmdy challengillg tsme. MaThty remains on the B08rd as a Trustee and we thank her for her LxJmmikn)enL We wdcome Mr ma￿ Hanis as the new Chair. up his post in D8cember 2022. Stral•gi¢ D&valopments Folknwng a development phase in 2021 and eaty 2022. we publis￿ our new Str8tegic Plan in Summer 2022. This was supportaj by intemal OF*rall￿1 arKJ Irting framework that has bgen applied in their prepardtion is appli(able Law and United KIWOM Acctyjnting Slandards, including Financial Reporbng Stsndard 102 The Financial Repoffjng Standartl awlicabl8 in fhe UK and Republic of Ireland IUnite(I lfjragdom Generalty A(xxpted Aowunting Practi￿1. In opinion, the finanoal ststements= give a tTue and fair view of the SL* of the chari¥s affair5 as at 31 Marth 2023 and of ils irM>)ming resour and applicatton of rvsources. for the year then erKled'. havo be￿ propedy pr￿re￿ in aoxx)rdaiK* ¥￿th United Kiwjom Ger￿[al￿ Ar￿U￿ting PrdGtice.' 8nd have been prEpared in accordan￿ wilh Ihe requirements of the ChariliesAct 2011. &xis for opinion We ￿ndUCted our audf( in accordan￿ with Intemattonal Standards on Audiling {UKI IISAS (UK)) and applicable law. Our responsibilities under those standards are further describgj in the AUdit0￿S responsibil￿eS for the audit of the finanual statements section of cojr rewrL We are indeperKlent of Ihe charity in accordance with the elhul requirements that are relevanl to our audit of the financxal stalernents in the UK. induding the FRC'S Ethical Stsndard. and we have fUffil￿d our i)ther ethical responsibilth.es rn atwrdan(x with these requirements. We believe that the audit evidence we have obtsined is and ap[KoW￿te to a basis for our opinion. Concluslons relating lo g￿n9 ¢oncern In auditing the financial statements. w8 have U)ndUd￿ that Ihe Tnjstees, us8 of the goirMJ concem basis of accounting in the preparation of the finarKial ststemenls is appropriate. Based on the work we have performed, we have not identifi811 any rnatertal un(xrtainties relating to events or conditions that. indiwdualty or o)Iledr¥ety. may (ast signrftcant doubt on the thaiity's abilty to continue as a going concem for a period of at kast tsvefve nM)nths frrmn vthen the financial statements are authorised for i&sue. Our responsitylities and the responsibilths of the Trustees wilh r8sp81A to going Lxjncem are de5C￿bad in the relevant sections of this reporL Other Inforniatlon The other infomiation comprises the inf0m￿bOn induded in the annual reFKrtt other than the finanaal statements and our auditorfs report thereon. The Trustees are responsible for the other information contsined within the annual report. Our opinion on the finanual statements dc￿ not cover the other information and we do r￿1 express any forni of assurance conclusion thereon. OL¢r responsibilty is to read the other infomiation and, in doing so. consider whether the other infomi8tion is m8terialty inix)nsislenl with the finan￿31staternents or our knovledge obtained in the course of the audtt, or otherwise app8ars to be materialty misslated. If we identify suth maiprial in¢>)nsistencies or apparent material misststements, we are required to detemiine vknether this givos riso to a material misstatsmgnl in th8 financial statements themsefves. If. based on the work we have perform8d. we condude that there is a matsrial misststement of this other infom)ation. we are required to report Ihat facl. We have nothing to report in this regard. Mattors on which we are requlred to report by exception We have nothing to report in respect of the folk)wing malters in Trtation to vthich th& Charitigs (A￿oUnts and Reports) R8gulalions 2(X)8 require us to ra￿rt to you rf. in our opin￿. the information given in the financAal statements 15 inLX)nsi5tent in any material resFect with the Trustees. sufficient aCc￿unting fe(x)rds have not been kept the financi81 ststements are not in agreement wtih the accounting records.. c we have not re￿ived all the infornation and explanation5 we require for our audiL 12- LINGEN DAVIES CANCER FUND CIO INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO Rasponsibllltle$ of Tru$tg8s As explained ￿rf)re fully in the statern￿ of T￿￿, ￿sibIlities. the Trustg8s ar8 r8Sw)nSib￿ for the preparation of the finantial statements and for being Satisfied thal th8y gNe a true and fair view. and for suth intemal control as the Tnjstees determine is necessary to enable the preparation of financbal statoments that are fr88 from material misstatemenL whether due lo fraud or er￿￿. In t*yriThJ the financial statements, the Trustees are responsible for assessiry the charrvs abilty to LX)ntinue as a going con￿rn. disthsing, as applicable. matters reLated to going concem and ￿￿ng the going concem basis of at))JuntiThJ unless the Twstees either intend lo cease operation5, or havo rKJ realistic altemative but to do so. Auditoes ro$p0nslblli￿os forthe audll of th• fhwKlal statemonts We have been appoint￿ as auditor under section 145 of the char￿eS Act 2011 repx)rt in accordance with the Act and relevant regulations made ￿ havirvJ effB(a 1tWBu￿ler. Our objectives are lo obtsin r8a$￿ab1e assuran￿ ab(yJt whether th& financial sLitements as a whole are free from material rnisststement. vthether due to fraLvJ CY error, artd to sssue an auditorfs rewyt that iftdudes our opinion. Reasonable assurance is a hvJh level of assurarte bth is nol a guarante8 that an audtt conducted in accordance with ISAS IUKI will a￿yE detect a matertal misstatement when ti exists. Misslatements can aTise from fraud or error and are considered material rf. irwJNidu8lly or in the aggregale. they (x)uld reasonably be expected to Influence the ecL)nomic decisions of users taken on the bas￿ of these financial statements. The extent lo whth our rvocedures are capable ofdetediw irregulatthes. frdud, detai18d below. we identtfied the lavts and regulatiorts applicable to thè Charity through discussions wtth the Twstees and other management, and from our knovAedge ar￿ experien￿ ofthe Charrty sector. we focused on speofic laws and regulatM)ns whid) w¢ considered may have a direct material effect on the financial statsments or the operations of the chanty. i￿udI￿j the Charity Act 2011 and laxation and data protect￿n,. Wg ensured that the man8gem8nt tèam coNectivety have the appropriate competence. capaiNlities and skills to identify or recwnise norp (#)Mplkqn￿ with applicable18ws and regulati￿$. and • identified laws and wulattons were o)mmunuled within the audil team rwjularty and the team remained alert to instsnces of r￿)n-￿mPlIan￿ thrrX￿h(rtrt the audit. We assessed the susceptibilty of the chari￿$ Iln8nc4d st*ements to mateTial mssststemenL i￿UdIr obtsinirrfJ an uThlerstanding of hLM fraLKI m¥Jht mwr. by: . maktThJ erNuiries of management as to V4here they ¢x)nsNJered there was suscepti￿￿[ty to fraud, their knowledge of actual, susp9Ct&d. aThJ alleged fraud. arKI considering the int&m81 Contro￿ in place to mikngate risks of fra￿ and nOn-￿mpl￿anc* wllh Lqws and regulations. To addrèss the risk of fraud thrixwJh managen￿nI bias and overrvje of tx)ntroL%. we: . performed analytic*l prctedures to Klentify any unLtsual or relationships: lesl joumal entries to identfy unusual transaclions. assess whether judgements and assUmptic￿S made in detemiining the accwnting estimates set out were indicative of potential bias. arKI • invesbgated the rationale behind Sbgntftcant ￿ unusual transactwm. 13- LINGEN DAVIES CANCER FUND CIO INDEPENDENT AUDrroR'S REPORT (CONTINUED) TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO In response to the risk of irregularibes and ncwmplkqrKe vrith la*s arKI regulations. we designed pro(*dvres which induded. bul were mt limited trj". agreeing finanaal statement dtsclosufes to undetyng SUpp￿ing dwjmentation" reading the minLrtes of meelings of those charged with gOveMar￿e. an(1 . enquirirKJ of managemer7t as to actual aTrJ [￿tIal Irbgation and d8im. There are inherent limitations in our audtt prowtures de￿￿bed above. The more removed that laws and regulation5 are from financial transacbons. the less likety it is that we W￿kj beojme aware of non- LL)Mplian￿. Auditing standards also limtt th8 audit [￿(￿edureS requirèd to identsfy non-compliance with laws and regulations lo enq¥Jiry of the trust￿ and other marogemenl aThY the Ins￿￿11￿ of regulatory and legal rresponden¢e, rf any. A further description of our re¥x)nsibifities is available on the Financial Repxxting CounrAI's website aL" hts'.11 www.frc.org.ukl3uditors￿p0n$lb1I[ties. This description forms part of our auditorfs repcmt. This report 15 made solely lo Ihe ￿mpan￿S members. as a b(￿, in ac(xydanc* vAth section 391 of the Cornpanies Act 2014. Our aLKlit work has been undertaken so that we miqht state tr) the companys mèmbÈrts those matters w8 are requiretl lo stste to them in an audttorfs rewt and for no other pur[￿￿. To the fullest exlent pem)itted by law, we do not accept or assumè responsibiltty to anyone other than the company and the u)mpany's members as a body. for our audit work. for this refKrt orfor the LwinNMs we have formed. Caerwyn Jones Chartered Accountants Statutory Audltor Emstrey House Shrawsbury Business Parf Shrewsbury SY2 6LG Caerwyn Jones is eligbi le for appoinlment as auditor of the charity by of its e]￿jIbIl￿ for app)inth)enl as 3udilor of a ¢omp8ny under section 1212 of the Companie5 20(6. 14- LINGEN DAVIES CANCER FUND CIO STATEMENT OF FINANCIAL ACTivrriES INCLUDING INCOME AND EXPENDITUREACCOUNT FOR THE YEAR ENDED 31 hlARCH 2023 Total Vnrnstricted Restrictsd funds funds 2022 2022 Total funds 2023 funds 2023 2023 2022 Income from: Donations and Èegaoes Charitable activib8S Other trading activities IrFvestments 891.189 891.189 25.240 286.OYT 598.749 44,636 884,826 44,636 25240 204,417 18.519 204.417 18.519 749 1,288 144,341 1232 145,0 2,520 Total incom• 1,114.125 25.240 1,139.365 288.114 788,958 1.077,072 dltufe on- FLiising fijnds 303.992 303,992 28.082 216.940 245,022 Charitable actsvittes 3%.872 32.044 428.916 133.897 812,830 946,727 Total expenditurn 71x1.864 32.044 732.W8 161.979 1.029.770 1.191,749 Net incom1￿(011￿0lng) resources boforo transfers 413,261 16.804) 406,457 126.135 {240,8121 (114.6771 Gross transfers be￿een funds 52.449 (52,449) Nèt incomellexpendltur•) for the yearl Net movemènt in funds 465.710 {59.253) 4￿.457 126,135 (240,812) 1114,6771 Fund balances at 1 April 2022 910.059 97.086 1.1x17.145 783.924 337.898 1.121,822 Fund tsalanc￿ at 31 March 2023 1.375.769 37.833 1.413.602 910.059 97.086 1.007,145 The statement offinancial acMie5 I￿￿ude$ 811 gans and k6ses rwniwy in the year. All income and expenditure dwive from continuiThJ a¢bv¥bes. 15- LINGEN DAVIES CANCER FUND CIO BALANCE SHEET ASAT31 MARCH 2023 2023 2022 FIX￿ assets Intangible assets Tangible assets 14 1S 8,{￿)0 100,382 86.494 108,382 Stoc*s Dèbtors Cash at bank and in hand 16 17 8,029 393.293 994.928 638 235,638 1.520,814 1.396.2S) 1.757.090 Creditors: amounts falling wlthfin one y￿r 18 (73.142) (858.327) Net currenl assets 1.323.108 898.763 Total assets less Ilabllltles 1.413.602 1.007.145 Income fund$ Restricted funts Unrestricied funds Designated ￿r￿lS General unrestricted funds 19 37.833 97.086 554.724 821.045 710.059 1.375.769 910,059 1,413.602 1,007,145 The an¢i81 st8tsm8tts wèr& aptKov•Y by Tntstees on ...(o.l.i.I1.2S Mr Harris (Chairman) Trustee 16- LINGEN DAVIES CANCER FUND CIO STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2023 2023 2022 Cash flows from opeTating a¢tivltles Cash (absorbed byygenerated from operations 1535.9881 748.833 Investing actlvfties Purchase of intangibla assets Purchase of tangl￿e fixed assets Investment In￿Me received (12.orx)) (98.120) 2.520 {8.417) 18.519 Net cash generated frOn￿(￿S￿d Inl Investing acti¥iUes 10,102 1107.600) Nel cash used in financing acllvlt Net Idecrease)nnCr￿s0 In cash and ¢ash oquivalents 1525.8861 639.233 Cash and cash equr¥aknts at beginning of year 1.520,814 881.581 Cash and cash equivalents at and of year 994,928 1,520,814 17- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023 Accountlng policies Charity inforn￿n Lingen Davies Cancer FuThJ CIO is a chaiitabte 1n(yjrF￿￿ 0￿Jar￿sati0n, registered in ErKJlarbd and Wales. 1.1 Accounting conventton The financial stslements have been prepared in acXXxdan￿ wtth Ihe chariws goveming d(wmen( the Charities Act 2011 and "Amnkn"ng and Rwtsrsg by Charities". Statsmgnt of Recommended Practice applicable lo chaftbes preparing thelr accounts in accordancs wFth the Finanaal Reporting Standard applicable in the UK and R8wblic of Irdand {FRS 1021- (as amended kjr accounling pgricxls comMen￿ng from 1 January 2019). The tharity is a Public ￿efft Entity as defined by FRS 102. The accourtts are prepar8d in sieE1ing. whK* is IITe funct¥)nal currerry of the charity. Monetary amounts in these finanryal statements are rounded to the nearesl £. The acxxlunts have been prepared on tr* histcrfKd c¥)st ￿nvenI](m. The winupal accounting pdicios adoptsd are set tjjt beknw. 1.2 Going concern At the time of approving th8 financial statements. the Trustees have a reasonable expectation thal the c*8rity has adequate resources to continue in Operati¢￿1 e￿$te￿ for the foreseeable ftrture. Thus the Tnjstees continue to adopt the going cmm basis of accounting in preparing the financial statements. 1.3 Charltable fiinds Unrestricted funds are availabte for us& at Ihe dis(*elion of the Trustees in fiJrtherance of their charitable objective5 un￿5 the furKls have bwi designalad for other wKtM)ses. Unrestricted funds are iknation5 arKI olher received for lh8 general obpcts of the tharity. Restricted funds are subject to stwfic (x)rKlitM)ns by d(￿18 8$ to may be used. The purposes and uses of the reslriGled funds are set out in the notes to the financial statements. 1A Incom• Irlcorne is recognised when the charity is legalty entitkd to it after 8ny performan￿ ￿ndItiOnS have been met, the arTh)unts can be m&*ured relk8ily. atKI it is WObab￿ thal inc(Mne wll recetV8d. Cash donations are recognised on ￿lPt. Other dox)ations are recognised once the Charity has been notified of the donation. Performan￿ condrtions require deferral of the amounl. In￿me tax recoverable in relation lo donations received under GiftAJd or dewjs of covenant is recognised al the time of the don8ti0n. Legacies are recognised C￿ re￿Ipt or olherwise rf the tharity has been not1r￿ of an impending dtstribution. the anK)unl is known, and receipt is expected. If the ar￿)￿nI is not known, the legacy is I￿ated as a crmtingent asset. Assets given for use by Ihe (tsiity are recognised re¢ervabl8. Income from government and other grants. whetsr'capitaf grants or'reV￿￿e. grants, is recognised when the tharity has enttdement to the funds, any performan￿ attad)￿l to the grant have been met. it is probable that the inoTh will be received the amount can ￿ measured reliab￿. Turnover is measured at the fair value of the ¢x>nsideration rec￿e￿ or receivable and represenls amounts re￿1vable for gcxx1s and servKos prov¥JwJ in the no￿￿1 u)ur5e of business. net of discounts. VAT ond other sales relat•¢l taxes. 18- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AIARCH 2023 A¢counting poli¢1oS Icontlnuod) 1.5 Exponditure Expenditure is recognised once there is a legal or construcbve rtjligation to transfer ecortomic benefft lo a third paty, il is wjbable that a transfer of ecorwnic benefiL% will be required in sewement. and the amount of thè Obl￿atIon c*n be measured reliabty. Exp8Nliture is dassffiwl by acts￿ty. Th (¥Jsts of eath actwity ar8 made up of the lotsl of direct costs and shared costs. including SuF￿rt costs imiolved in undertaknng eath actsw. Dire(a Costs altributable to a sÉngle acbwty are alk￿ted directly to that a(*vtty. Shared o)5ts whth contritwjte to rnore than one activity and support costs which are not aknb[tsb￿ lo a Sing￿ activity are apportioned t*tr4een those 8th"v￿e$ on a basis consist8nt with Ihe use of rèsour￿. Central staff ulsts are alkKalèd on the basis of b.me spent. and d$preciation charges are allocated on the FMyti(M) of the asseys ustr. Olrect Charltable Expendlturn The objects of Ihe charity are to rase fijnds to tmide grdnts to support the work of cancer health care professionals for the treatrnent of ￿n￿r patients in Shropshire. Telford and Wrèknn and Mid Walgs, the provision of seThices directy to ￿nCer patients and r8ising awarene55 of cancer prevention in the area. Any expernliture speufi(81ty to athieve these oI49(ts is induded in dirnct tharItab￿ exp￿￿1￿Tr. G0￿ManCe costs Administration expersses of th6 charity relale to the t*&sts of r￿r￿n9 th¢ charity. gjch as insurance. accountancy fees and Lxjsts of ststtrtory complian(*. aThl indude any ￿$ts which cannot be specificalty attributed to another expendilur8 dassificalion. 1.6 Intanglble fixod assets otherthan 9oodwill Intangible a&sets acquired separatety from a busFness are reLxyJnised at cost arml are subsequenty measured at I￿* kss acuJmuL*d amortisation and ac(wmulat8d impairment losses. Intsngible asse15 a￿Uired on busine55 1))mbinations are wxyJnised separately from goodwill at the acquisition dale wher8 tt is probable that the expethd fiJture e(x)nomic benefits that are attributable to the asset will flow to the entity and the fair value of the asset be measured reliably. the Intangib￿ asset arises from COFrtractual or other18gal rithts; the lntaTrj￿ asset separdble from th8 entity. Amortisalion is recognised $0 as to write off Ihe rx*t or valuation of 8ssets ths their ￿5**Ual values over their useful lives on the fiAlowiThJ bases.. Website 3333% pA. cm (ost 1.7 Tangible fixod assets Tangible fixed assets are in￿alty measured at cost aTrJ sub5equw)ty Thasured at o)st or valuation, net of (leprech3tion armj any impaimient Josses. DeprerAalion is recognisod so as to write off the cost or vabJalion of 8SSgts 18ss their residual values over their Useful INes on the folh)wing bases: Equipment Sofvlare Motor vehides 33.33% p.a on tx* 20% p.8 on cost The gain or loss arising on thè dIsK￿l of an asset is d￿eM)In￿d as Ihe diffeTence belweèn the sale prO￿e<1S and the carrytng value of the asseL and is recognised in the staterrEnt of financial actÈvities. 19- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Accountlng polldas {Contlnued) 1.8 Impalrn*nt of fixed assets At each reporting end date. the charity reviewE the carrying amounts of its tsrrfjible and intangibie assets to deterniine whether the￿ is any I[￿[Ca￿On that those assets ￿e suffered an Impalm￿nI loss. If any such indication exists, the recoverable amount of the asset is estimated in order to delemiine the extent of the impairment loss lrfanyl. 1S Stocks Stocks are stsled al the lower of cost and estimated selliTrJ Pri￿ less costs to complets and sell. Cost comprises direct materials and, whero app1[￿ble. direct LgiK)ur (x)sts aTrJ those ovefheads that ha￿ b88n incurred in briThJing the stocks to thèir w8sent and t>)ndtbon. lÈems held for distribution at no or nominal consideration are measured al ts lower of replacement o)st aThJ cost. Net r8alisable value is the estimated selling pri￿ ￿ all estimated costs of ¢C¥np18￿n and (t)sts to be incurred in marketing. selling and distribution. 1.10 Cash and cash equivalents Cash and cash equivalents indude cash n hand. deF*)sts hekl at ￿11 with banks arnl other short4erm liquid invesknents wlth original rnaturibes ofthree m(￿S or less. 1.11 Employ•0 bèn The cost of any unused hdiday èlltillement is re(rynised in Ihe perKxJ in which the empW&'s sgNieo$ are receivad. Tominalion benefits are reLwnised iMMed￿lety as an expe￿ when the thaiity demonstrabty L*)mmitted to tèmiinate the employTnent of an employee or to termination beneffts. 1.12 Rètlr•m•nt b¢nèfits Payments to define(l (xjntrsbution retirement benefft srkn are charged as an expense as they f811 due. 1.13 Dobtors Debtors are rec(NJnised at the setuefflellt arrwnt due after any discount Off￿ed. 1.14 Creditors Creditots are reoyjnlsed where the charrty has a Present oblvJalM)n rnsulling from a past event that wll probably result in the transfer of fvnds to a third paty and the amount due to sewe the obligation can be measured or estimated reliabty. c￿rtarS and F*ovisions are rwJnised at their setU8M￿t am(￿ftt. LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMEKfs (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Donations and lega¢i Totsl funds funds 2023 2022 2022 2022 D¢)nations and gilts Legacyes receivable Grants rweivable 617.IY26 266,692 7,471 117.394 164.315 4.368 4(KJ.004 5.000 193.745 517.398 169,315 198,113 891.189 286.077 598.749 884,826 The amounts sh￿n above indLKle unpaid legacies *thich due to the time a￿1 Comp￿XI￿ taken for kgaaes to crystallise. this income may not be reCe￿j wrthin 12 rt￿th$. Wthn debtors at the year end unpaid leg8Lies amount to £348,98412022= £157.711). CJRS Grant Other Grants 334 197.779 7.471 4.034 193,745 7,471 4.368 193.745 198,113 Charftable a¢llvhl•s se￿iCe delivery 2023 Sèrvlcg d•llvory 2022 LtveLrfe 25240 44,636 Total fund$ nds 2023 2022 2022 Fundraising events Merchandise 188,787 15.630 749 123.271 21.070 124.020 21,070 204.417 749 144.341 145.0 -21 LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Total fvnd$ nds 2022 2022 2022 Investmont In￿Me 18.519 1.288 1.232 2.520 Raising funds Total fund5 funds funds 2022 2022 2022 Fundraisin Seeking donations. grants and legaci&8 Staging fundralsing ever Advertising Other fUndraisiT￿ costs staff costs Support (¥Jsts 1.324 68.194 4222 7.462 139.870 75.108 8,174 395 1.346 18.167 37,935 7.144 9.534 149.134 46,109 7,539 10.880 167.301 Fundraising and pU￿1￿ty 2%.180 28,082 203.747 231.829 Tradin Mo￿handl$￿ 7.812 13.193 13.193 303.992 28.082 216,940 245,022 LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Charitable acllvltles Total 2023 Granl maklng 2022 Total 2022 delivery 2023 making 2023 delivery 2022 Slaff costs LiveLtfe 65,723 26,342 65.723 g2.C65 92.065 Grant funding of activities (see note 8) 202.229 202229 829.928 829,928 Share of suprx)rt Costs {see note 91 Share of govemance sts Is88 note 9) 57.527 75.108 132.635 114,1 114,190 1.324 1.987 2.609 150.255 278.661 428,916 116.799 829,928 6,727 Anatysls by Unreslricled funds Restricted funds 118211 278.fj61 396.872 32.044 116,799 17.098 812.830 133,897 812,830 150.255 278.661 428.916 116.799 829.928 946,727 Grants payablo Grant making 2023 Grant making 2022 Grants to instsiutions: Clinical Nurse Specyalists Clini¢ Rooms CT Scanner ican Programme Scalp Cooling Cap Hamar Conter Exlension Complementary Therapies War¢J 23 TVS Radar Keys lQck Cartsr 617 372,455 440.375 3,000 164.100 15.353 3,465 11,1 1.512 2,018 633 10,000 202,229 829,928 Grants payable from unrestrithd tunts arrv)unt to £202229 {2022: £17.0981 and from restricted funds £nil12022.. £812.8301. -23- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Support costs Support G¢Nernnce Support Govemance 2022 Staff costs Depr8ciatK)n Overheads Trdining 140.293 26,305 32.825 140.293 96.010 5.404 8.033 4.743 96,010 5,404 8,033 5,132 32.825 8.320 389 Audit fees Trustee indemnty instjran Legal cx 1.750 1.750 470 470 1.371 1.371 207.743 3.311 211.054 114.1 2.609 116,799 Analysed betsveen Fundraising Charitable activities 75.108 132.635 1.324 1,987 76.￿2 134.622 114.1 116.799 207.743 3.311 211.054 114,1 2,609 116,799 Support and 9)verna￿￿ wsts have been alkx*d based on the trustees eS￿rnated costs incurred being 40% to fundraising. 40% to grant rnaking and 20% to semce detivery as well as the depreciation expensg 0 the van. 10 N•t mov•ment In tsnds 2023 2022 Net movement in funds is stated after 0*argin￿(C￿9dl1lng Fees payable to the companys a￿ditor for the audit of Ihe cxMnp8n*s finan(aal stslements Depreciation of ownpAJ taThJible assets ArrK)rbsation of intsngible assets 1,750 1.404 22.305 11 Trust¢os None of the Tntstees (cf any pe￿ft$ (X)nnec￿l with them) receiv&J any remunerdt¥Jn or benefits from th8 charity during the year. During the year the charity r￿￿ed d(ThtK)ns from nir￿ trustee5 {2022: nine), wiUx)ul ujndilions totalling £1,837 {2022'. £3.7561. -24- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 12 Employ8os The average mcmthty number of empbyees the year was: 2023 Number 2022 Number Administratwjn 12 Employment c¢>sts 2023 Wages and salari8S So(ial W￿rity costs other ￿nSIOn Costs 298,718 27,676 19.492 224.940 20,074 18,297 345,886 263.311 Thers were no emptoyees annual remur*ralK*) was more than £60.(￿. 13 Taxation The charity is exempt from tsx on Incorr￿ aThJ gains falliw within wbon 505 ofthe TaxesAct 1988 or sectif 252 of the Taxationof Chargeable GartsAct 1992 to the extent th81 tss8 are applied to its charitable objects. 14 Intsnglble flxed assets Websi At 1 April 2022 and 31 March %)23 12,000 AmortI&￿i0n and impalm*nt Al 1 April 2022 AmOrtiSa￿On charged for the year 4,000 At 31 March 2023 8.000 Carrylng amount At 31 March 2023 At 31 March 2022 8,000 -25- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 15 Tangibk fix•d assets Total Cost Al 1 April 2022 Additions 13.775 13,980 95.400 4,464 123,155 8,417 At 31 March 2023 17,728 13.980 99.864 131,572 Dèproclatlon and Impalm￿nt At 1 April 2022 Detwialion charged in the year 8.793 2.332 13.980 22.773 22,305 19,973 At 31 March 2023 11.125 13.980 19.973 45.078 Carrying amount Al 31 M8r¢h 2023 6.603 79.891 86,494 At 31 March 2022 4.982 100,382 16 Stocks 2023 2022 Fiftished goods and goots for resale 8.029 17 Debtors 2022 Amounts falling due wlthln yoar. Trade debtors Prepayments and accsued KKome 1.315 391,978 52,975 182.663 393.293 235,638 18 Creditors: amounts falling due within one year 2023 2022 ACc￿￿lS aThJ deferred inc(m 73.142 858,327 00 ooub oots) ooty oorD LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Designated funds The income funds of the charity indude Ihe f￿1￿41￿j deswnated %thic* have been set asKle out of iJnrestrict8d furKJs by the trustees for specific in fund5 l AWA 2021 31 March 2023 Running costs Powys livelife 200,000 357,642 354,724 (2.9181 2CM).( (2.9181 357.642 554.724 21 Analysis of net assets between lunds Unrestrlcted Restrlcted 2023 Total Unrestrlctsd R•strlctsd 2023 2022 2022 Totsl 2022 Fund b8lan¢es at 31 March 2023 are r8pr6s8n1￿ by: Intangible fixed assets Tangible assets Current assetsllliabilitiesl 8.000 100.382 898.763 86.494 1.285.275 86.494 1.323.108 11X).382 801.677 37.833 97.086 1.375,769 37.833 1.413.602 910.059 97.086 1,007,145 -28- LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Purpose of fvnd$ {mat•rial funds ontyl Unrestri¢ted funds The unreslrided reseNes rep￿Sent arnjmulated funds re(*ived whth are free to be used w(fhin the objedives of the charity. These funds are available for the future fijnding needs and working capital of the charity. The Tunning (x)st reserve is a fuThl set awde to meet the 12 runniThJ costs of the L*Jarity, rf funding sources ￿Sed or reduced. The Powys Pmject Fund was set asKle from a W rec*lwY in 2021122. 11 is being used to extend the veLtfe and ican project WOFk to the Powys aw. 2079-21 Appeal A new appeal w8S Started in 2019 to ravse furlhw fijnds to a$￿st SaTH wlh nèw proi8cts. We agreed to fttndraise approx £370.000 fLY an extension to the Ltngen Davies dinic rooms and £450.000 for a new CT Scanner for the Radiotherapy doparbnent. These prOj￿ts werg delayed by 12 month5 because of Covid~19 but were completed in March 2022. The balan￿ left in the Appeal has been althated to buying chemotherdpy C￿1 Caps in 2022r23. the remaining fuTrJs going to ts ican wciecL veLrfe The charity is worknng with NHS shr0psh￿e Teworrj and Wreknn to deliver the C￿20* project. designed to increase the uptake of (2ncer screening in Telford and Wrekin. 23 Capital eommitments In addition lo the grants akeady mwje in Note 8, at the end of the year. the Charity has committed to pay grants from Current funds and fulure rnisir¥J for the foll0v￿ry. Unrestricted funds Auto Contouring ican Programme £16.216 Related party transactlons Ramuneration of key manag￿￿TrI p•Tronn The remuneration of key Manage{T￿nt porsonnel is as fcI1￿¥s. 2023 2022 Aggregate compensation 149.659 116,009 Transa￿orva wlth related wrties During the year trustees purthased merrjlar￿￿￿e arHI tidtets for events from the tharity at full r))st totalling £50212022: £5461. LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMEKfs {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2023 Related party transactions {Continued) AbbeyFgsl wds a projeca in knngen Davies w￿k￿l in partwship th Shrewsbury Abbey. Pop Up Shrop Ltd and Total Hospitaltty & Events Management Pop Up Shrop Ltd and Totsl Hospilalty & Events Management are owngd arKJ managed by Darren Tomki￿. wlK> is the parther of the Lingen Davies CEO. Darren was paid a discounted management fee and all other items were invoiced to the charrty at ￿$t. The totsl paid was £5,226 {2022: £5,970). The b3￿r￿e owed at the year end was nil for 2D23 and 2022. Dyke Yaxley Ltd. in whith Mrs F K Hutcheson vrd5 Director. supplied the charivs acwunting software at a annual cost of £374 12022.. £346). payrdl Se￿￿5 at a (x)st of £360 {2022.. £3061 and also assist wtth thè preparatK)n of the Financial Stst￿nts (m a pro basis. The balance al th8 year end was nil for 2023 and 2022. 25 Cash 9enerated from operations 2023 2022 S￿￿V$1(de￿¢ItI for th& year 406.457 1114,6771 AdSuslments for. Inveslmenl income re￿jnI$ed in statement of fironcial athil Amortisation and impaimient of intangible assets Depreciation and impaiTment of tangitAe fixed assets 118,5191 4,0 22.305 {2,5201 4,OLIO 1.404 Movements in working capital.. Ilncreaseydecrease in st Iln¢reaseydecrease in debtors IDecreaseyin¢re8se in crÈ(litors 17.391) (157.655) (785.185) 1.581 163,820 693,225 Cash labsorbod byVg•noratsd from oprndons (535,988) 746,833